This guide is continuously monitored and updated by our AI compliance engine. It tracks legislative changes, board rulings, and regulatory updates for Ohio in real time — so you always have the most current compliance intelligence.
The telehealth compliance information for Ohio presented on this page is provided for general informational purposes only and should not be construed as legal advice. The telehealth regulatory landscape is evolving rapidly, with state legislatures, medical boards, and federal agencies frequently updating rules, guidance, and enforcement priorities. While TrueEval makes every effort to keep this information current and accurate, we cannot guarantee that all details reflect the very latest regulatory changes at the time of your visit.
We strongly recommend consulting with a qualified healthcare attorney or compliance professional before making business decisions based on this information. For the most current regulatory requirements, refer directly to your state medical board and relevant licensing authorities. Last reviewed: February 2026.
Ohio presents a dynamic and generally favorable regulatory environment for healthcare companies, balancing patient protection with an openness to innovative care delivery models, particularly in telehealth. The state has actively embraced telehealth expansion, especially accelerated by the COVID-19 pandemic, and has codified many of these changes into permanent law. Key regulatory bodies include the State Medical Board of Ohio (SMBO), the Ohio Board of Nursing, the Ohio Board of Pharmacy, and the Ohio Department of Health. Ohio's business climate is generally supportive, but healthcare entities must navigate specific licensing, corporate practice of medicine (CPOM), and prescribing regulations. Recent legislative actions have focused on solidifying telehealth parity, addressing controlled substance prescribing, and refining scope of practice for various professionals. While not as restrictive as some CPOM states, Ohio does maintain a stance that requires careful structuring, particularly for non-physician-owned entities providing medical services. The state's approach emphasizes patient safety and quality of care, necessitating robust compliance programs for any entity operating or expanding within its borders. Companies looking to leverage telehealth for services like weight loss, hormone therapy, or mental health will find a relatively clear, albeit detailed, regulatory framework. The state has shown a commitment to reducing barriers to care while maintaining oversight, making it an attractive, yet complex, market for healthcare innovation. Understanding the nuances of professional licensing, the permissible modalities for establishing a patient-provider relationship, and the specific rules for prescribing controlled substances via telehealth are paramount for successful and compliant operations.
Ohio maintains a form of the Corporate Practice of Medicine (CPOM) doctrine, though it is not as strictly enforced or explicitly codified as in some other states. The legal basis for Ohio's CPOM doctrine primarily stems from judicial interpretations and the professional licensing statutes that prohibit unlicensed individuals or entities from practicing medicine or employing licensed professionals to practice medicine on their behalf. The core principle is that medical decisions and the delivery of medical care must remain under the direct control and responsibility of licensed physicians. Ohio Revised Code (ORC) Chapter 4731, governing physicians, and other professional practice acts implicitly support this doctrine by defining who can practice and under what conditions. Specifically, ORC 4731.41 prohibits the corporate practice of medicine by stating that "No person shall practice medicine and surgery, or any of its branches, without a certificate from the state medical board." This is interpreted to mean that a corporation, as a non-person, cannot hold such a certificate and therefore cannot directly practice medicine. While non-physicians generally cannot own entities that directly employ physicians to provide medical services, Ohio does permit certain exceptions and alternative structures. Professional corporations (PCs) or professional associations (PAs) are explicitly allowed under ORC Chapter 1785, which permits licensed professionals to form corporations for the purpose of rendering professional services. However, ownership of these PCs/PAs is typically restricted to licensed professionals within that specific profession. For example, a medical PC must be owned by physicians. This means that non-physicians generally cannot own a medical practice that directly employs physicians. This restriction significantly impacts telehealth companies, medspas, dental practices, and wellness clinics. For telehealth companies, a common compliant structure involves a Management Services Organization (MSO) model. Under this model, a non-physician-owned MSO provides administrative, non-clinical services (e.g., billing, marketing, IT, facilities) to a physician-owned professional entity (PC or PA) that directly employs or contracts with the licensed providers who deliver clinical care. The MSO cannot control clinical decisions, set physician compensation based on referrals, or engage in fee-splitting. Medspas, dental practices, and wellness clinics face similar considerations. If these entities offer services considered the practice of medicine (e.g., injectables, laser treatments, certain IV therapies), the clinical component must be owned and controlled by licensed professionals, typically through a PC. Non-physician ownership of the MSO providing management services is permissible, provided the MSO strictly adheres to non-clinical functions and avoids any influence over medical judgment or patient care. Dental practices are similarly governed by the Ohio Dental Board, and direct corporate ownership by non-dentists is generally prohibited for entities providing dental services. The key restriction is that the entity providing the professional service must be owned by licensed professionals of that discipline, or structured to ensure clinical autonomy and avoid CPOM violations. Ohio's CPOM doctrine necessitates careful legal structuring to ensure compliance, particularly for multi-state operations or those involving non-clinical investors.
Ohio has established a robust framework for telehealth, largely codified in Ohio Revised Code (ORC) 4743.09 and various board rules. A provider-patient relationship can be established via telehealth, provided it meets the standard of care that would apply to an in-person encounter. The SMBO's rules, particularly Ohio Administrative Code (OAC) 4731-11, outline the requirements for establishing this relationship. It generally requires a legitimate medical purpose and a documented medical evaluation. While an initial in-person visit is not explicitly mandated for establishing a relationship in all cases, the provider must exercise appropriate medical judgment to ensure the telehealth encounter is sufficient for diagnosis and treatment. Ohio permits a broad range of telehealth modalities. Live interactive audio-visual (video conferencing) is the preferred and most widely accepted modality for establishing a new patient relationship and delivering complex care. Audio-only (telephone) encounters are also permitted, particularly for follow-up care, mental health services, and when video is not technically feasible, but providers must ensure the standard of care is met. Asynchronous (store-and-forward) technology is permissible for certain applications, such as radiology or pathology interpretations, but generally not for establishing a new patient relationship or primary diagnosis without supplemental synchronous interaction. There are no specific telehealth registration requirements for providers beyond their standard professional licensure in Ohio. However, out-of-state providers must be licensed by the appropriate Ohio professional board to provide telehealth services to Ohio patients, unless they qualify for an interstate compact (e.g., IMLC, PsyPact). Informed consent is a critical component of Ohio telehealth law. Providers must obtain informed consent from patients prior to delivering telehealth services. This consent should include information about the nature of telehealth, potential risks and benefits, privacy and security measures, and the patient's right to withdraw consent. Documentation of this consent is required in the patient's medical record. ORC 4743.09(B) specifies that a health care professional providing telehealth services must ensure that the patient has given informed consent. There are generally no geographic restrictions within Ohio for telehealth services, meaning a licensed Ohio provider can treat a patient located anywhere within the state. However, providers must be mindful of their own licensing board's specific rules and ensure they are licensed in Ohio to treat Ohio residents.
Ohio has specific and evolving rules regarding the prescribing of controlled substances via telehealth, largely governed by the State Medical Board of Ohio (SMBO), the Ohio Board of Pharmacy, and federal DEA regulations. As of 2025-2026, the federal flexibilities granted during the COVID-19 Public Health Emergency (PHE) regarding prescribing controlled substances without an in-person visit have largely been integrated or modified. Generally, for Schedule II-V controlled substances, a legitimate patient-provider relationship must be established. While the federal DEA has proposed rules that would require an in-person examination for initial prescriptions of Schedule II medications and certain Schedule III-V narcotics via telehealth, Ohio's state regulations often align with or are more restrictive than federal guidelines. For Schedule II controlled substances, an in-person examination is typically required for the initial prescription. Subsequent refills or adjustments may be managed via telehealth if the provider has established a bona fide patient-provider relationship and deems it medically appropriate. For Schedule III-V controlled substances, an initial telehealth encounter (preferably audio-visual) can establish the patient-provider relationship, allowing for prescribing, provided the provider adheres to the standard of care. The SMBO's rules (OAC 4731-11) emphasize that a valid patient-provider relationship is essential for all prescribing, including controlled substances. DEA requirements mandate that providers prescribing controlled substances must have a valid DEA registration associated with their practice location. For telehealth, the prescribing provider's DEA registration must be tied to a physical location where they are authorized to practice. Ohio law mandates checking the Ohio Automated Rx Reporting System (OARRS), the state's Prescription Drug Monitoring Program (PDMP), before prescribing or dispensing an opioid analgesic or benzodiazepine, and periodically thereafter. ORC 3719.06 and OAC 4731-11-04 detail these requirements, including specific timeframes for checking OARRS. This applies to all prescribing, including telehealth. Quantity and refill limitations for controlled substances are consistent with in-person prescribing rules. For example, Ohio law places limits on the initial prescribing of opioids for acute pain (e.g., 7-day supply for adults, 5-day supply for minors, with exceptions). These limitations apply equally to telehealth prescriptions. Special rules apply to specific drug classes. For GLP-1s (e.g., for weight management), testosterone (hormone therapy), and stimulants (e.g., for ADHD), these are often Schedule III or IV controlled substances. Prescribing these via telehealth requires strict adherence to the established patient-provider relationship, comprehensive evaluation, and OARRS checks. Providers must demonstrate medical necessity and appropriate monitoring. The SMBO has been vigilant in enforcing proper prescribing practices, especially for controlled substances, regardless of the modality of care delivery. Any telehealth company prescribing these medications must have robust protocols in place to ensure compliance with both state and federal regulations.
Ohio's scope of practice for mid-level providers such as Nurse Practitioners (NPs) and Physician Assistants (PAs) is defined by their respective professional boards and statutes. Ohio does not grant full practice authority to NPs. Advanced Practice Registered Nurses (APRNs), which include NPs, Clinical Nurse Specialists (CNSs), Certified Nurse-Midwives (CNMs), and Certified Registered Nurse Anesthetists (CRNAs), operate under a 'standard care arrangement' (SCA) with a collaborating physician. ORC 4723.431 outlines the requirements for SCAs. An SCA is a written, formal agreement between an APRN and one or more collaborating physicians that establishes the scope of the APRN's practice, including prescriptive authority. While the SCA provides a framework, the APRN is ultimately responsible for their own practice. The collaborating physician does not need to be physically present but must be available for consultation and review of patient cases as specified in the SCA. For Physician Assistants (PAs), Ohio law (ORC 4730) requires them to practice under the supervision of a supervising physician. PAs can perform medical services that are within their education, training, and experience, and are delegated by their supervising physician. The supervising physician is responsible for the PA's actions. While the supervising physician does not need to be on-site, they must be readily available for consultation. Ohio law allows for a 'supervision agreement' between a PA and a physician, detailing the scope of practice and supervision parameters. Delegation rules for Medical Assistants (MAs) in settings like medspas are critical. MAs in Ohio generally cannot perform tasks that require independent medical judgment or that constitute the practice of medicine. Their scope is limited to administrative and certain clinical support tasks under the direct supervision of a physician, PA, or APRN. For example, MAs cannot perform injectables, laser treatments, or other procedures considered the practice of medicine. These procedures must be performed by a licensed physician, APRN, or PA within their scope of practice and under appropriate supervision. Any delegation must be consistent with the MA's training and the supervising professional's license. For medspas, this means that procedures like Botox injections, dermal fillers, or advanced aesthetic treatments must be performed by appropriately licensed and supervised professionals. Supervision requirements vary by profession and the specific task. For NPs, the SCA defines the collaborative relationship. For PAs, a supervising physician must oversee their practice. The level of supervision can range from direct (physician on-site) to indirect (physician available by telecommunication), depending on the complexity of the task and the experience of the mid-level provider. Companies must ensure that their operational protocols strictly adhere to these state-specific scope of practice and supervision requirements to avoid unauthorized practice of medicine or nursing.
Navigating Ohio's Corporate Practice of Medicine (CPOM) doctrine necessitates careful business structuring, with the Professional Corporation (PC) and Management Services Organization (MSO) model being the most common compliant approach. PC-MSO Structures: This model is essential when non-physicians (e.g., investors, entrepreneurs, or non-clinical entities) wish to own or control the business aspects of a healthcare enterprise that provides services considered the practice of medicine. The PC (or Professional Association, PA) is a separate legal entity owned solely by licensed healthcare professionals (e.g., physicians for a medical practice, dentists for a dental practice). This PC employs or contracts with the licensed providers who deliver clinical services. The MSO, which can be owned by non-physicians, enters into a Management Services Agreement (MSA) with the PC. The MSO provides all non-clinical administrative and business support services, such as billing, scheduling, marketing, facilities, IT, and human resources. The MSA must clearly delineate that the MSO has no control over clinical decision-making, patient care, or provider hiring/firing related to clinical competence. Fee-Splitting Rules: Ohio has strict prohibitions against fee-splitting, which generally refers to the division of professional fees with unlicensed individuals or entities for patient referrals or services. ORC 4731.22(B)(11) prohibits a physician from
Ohio's regulatory landscape for healthcare is continuously evolving, with several key developments and pending legislative actions anticipated for 2024-2026. One significant area of focus continues to be telehealth. While many pandemic-era flexibilities were codified, the State Medical Board of Ohio (SMBO) and other professional boards are refining rules to ensure patient safety and quality of care, particularly concerning the establishment of patient-provider relationships and controlled substance prescribing. There's ongoing discussion, often influenced by federal DEA proposals, regarding the necessity of initial in-person visits for certain controlled substance prescriptions via telehealth. Companies should monitor proposed changes to OAC 4731-11. Another area of legislative activity involves scope of practice for Advanced Practice Registered Nurses (APRNs). While full practice authority remains elusive, there are perennial legislative efforts to expand APRN autonomy, particularly regarding the requirements for standard care arrangements (SCAs) and prescriptive authority. Any changes here could impact staffing models for telehealth and brick-and-mortar practices. Ohio has also been active in interstate compacts. The state is a member of the Interstate Medical Licensure Compact (IMLC), facilitating expedited licensure for physicians. It is also a member of the Psychology Interjurisdictional Compact (PsyPact) and the Nurse Licensure Compact (NLC), which streamline licensure for psychologists and nurses, respectively, across participating states. Companies employing these professionals for telehealth should leverage these compacts for multi-state operations. Recent board actions have often focused on enforcement related to improper prescribing of controlled substances, particularly opioids and stimulants, and violations of the Corporate Practice of Medicine doctrine where non-licensed individuals exert undue influence over clinical care. The SMBO has also issued guidance and taken action against providers engaging in inappropriate prescribing practices for weight loss medications or hormone therapies without adequate patient evaluation. Companies should monitor the SMBO's disciplinary actions and guidance documents for insights into enforcement priorities. Furthermore, there's a growing legislative interest in regulating direct-to-consumer telehealth advertising and ensuring transparency in pricing and services, which could lead to new compliance burdens for digital health platforms.
For healthcare companies entering or expanding in Ohio, a proactive and meticulously planned compliance strategy is essential. Here's a practical, step-by-step guide:
This article outlines the Centers for Medicare & Medicaid Services (CMS) requirements for healthcare providers offering telehealth services, focusing on credentialing and Medicare enrollment. It details the specific regulations and flexibilities that impact providers seeking to bill Medicare for virtual care, emphasizing the importance of compliance for continued participation.
State dental boards are actively defining the scope and standards for teledentistry, impacting how dental professionals can provide remote care. These regulations often address patient-provider relationships, technology requirements, consent, and record-keeping, emphasizing parity with in-person care standards. Compliance is crucial for dental practices expanding into virtual services to avoid regulatory scrutiny.
The provision of IV vitamin therapy and hydration services via telehealth requires strict adherence to state-specific regulations regarding the establishment of a valid practitioner-patient relationship, physical examination requirements, and supervision protocols. Many states mandate an in-person initial examination or specific telehealth modalities to ensure patient safety and appropriate medical oversight for these invasive procedures. Healthcare businesses offering these services must meticulously review and comply with the medical practice acts and board rules of each state where they operate.
Medspas leveraging telehealth for oversight across multiple states face complex and varying medical director requirements. Understanding the specific state laws governing physician supervision, corporate practice of medicine, and telehealth regulations is crucial for compliance and avoiding legal pitfalls.
The FDA has issued multiple warnings and guidance regarding the use of compounded semaglutide and tirzepatide, emphasizing that these compounded versions are not FDA-approved and may pose risks. This regulatory stance significantly impacts telehealth weight loss programs that rely on these medications, highlighting critical compliance considerations for prescribers and pharmacies.
Full physician-led clinical encounters with prescribing authority — real provider-patient relationships, not just clearance visits.
Board-certified medical directors for telehealth platforms, medspas, IV therapy clinics, dental sleep medicine, chiropractic practices, and more.
Structured agreements between physicians and mid-level providers ensuring compliant care delivery.
Navigate Corporate Practice of Medicine laws with state-specific compliance frameworks and legal structures.
Systematic clinical documentation reviews ensuring quality standards and regulatory compliance.
Receive instant notifications when Ohio changes healthcare regulations.
Subscribe to AlertsGet a customized compliance framework for your healthcare operations in Ohio — telehealth, medspa, IV therapy, or brick-and-mortar. Our team will guide you through every regulatory requirement.